Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 16, Issue 2, 2002, Pages 204-209

  Tomita, T ^a   Fukuda, Y ^a   Tamura, K ^a   Tanaka, J ^a   Hida, N ^a   Kosaka, T ^a   Hori, K ^a   Sakagami, T ^a   Satomi, M ^a   Shimoyama, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; ANTIINFECTIVE AGENT; PROTON PUMP;

ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; ERADICATION THERAPY; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH ULCER; TREATMENT OUTCOME; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; ISOLATION AND PURIFICATION; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; PEPTIC ULCER; PROTON PUMPS; RECURRENCE; TREATMENT OUTCOME;

EID: 0036551380     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.16.s2.24.x     Document Type: Article

References (11)

1. Wyatt JI, Dixon MF. Chronic gastritis-a pathogenetic approach. J Pathol 1999; 154: 113-24.
2. Peterson WL, Lee E, Feldman M. Relationship between Campylobacter pylori and gastritis in healthy humans after administration of placebo and indomethacin. Gastroenterology 1988; 95: 1185-97.
3. Valle J, Seppala K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of H. pylori; a morphometric study. Scand J Gastroenterol 1991; 26: 1057-65.
4. Rauws EAJ, Tytgat GNL. Cure of duodenal ulcer associated with eradication of H. pylori. Lancet 1990; 335: 1233-5.
5. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437-42.
6. Hentscell E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of H. pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 312: 308-12.
7. Eslick GD, Lim LL, Byles JE, Xia HH, Tally NJ. Association of infection with gastric carcinoma: a meta analysis. Am J Gastroenterol 1999; 94: 2373-9.
8. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-69.
9. Arakawa T, Higuchi K, Fujiwara Y, et al. Helicobacter pylori: criminal or innocent bystander? J Gastroenterol 2000; 35 (Suppl. 12): 42-6.
10. The European Helicobacter pylori Study Group. Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41: 8-13.
11. Van der Hulst RWM, Rauws WAJ, Koycu B, Keller JJ, Bruno MJ, Tussen JGP, Tytgat GNJ. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113: 1082-6.